Clinic Research Nurse

It’s More Than a Career, It’s a Mission.

Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.

Our Mission

People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.

As an

Oncology Research

Nurse

your

primary responsibility is to screen, enroll and follow oncology research study subjects ensuring protocol compliance and clo

se monitoring while patients

are on

the

study. You

are responsible for

all data collection, source

documentation

and submission of adverse experience reports.

You will s

upport

enrolling patients

onto

clinical trials through recruitment, screening,

enrollment

and follow up

of

eligible subjects.

You will ensure

the protection of study patients by

timely

adherence to protocol req

uirements and

compliance

You will attend

weekly study status teleconfer

ence and monthly staff meetings

You will be

familiar with the protocols on which the patients are enrolled, screen, treat, and follow patients

You will review

the study design and inclusion / exclusion criteria with physician and patient.

You will c

omplete and document screening / eligibility and consent accurately and have all parties fully execute the document including HIPAA Authorization

You will c

omplete the inclusion / exclusion form and standard enrollment form accurately and assess the patient and document findings at each clinic visit while on protocol

You will d

ocument all specific tools required by the protocol (

i.e.

oral medication forms, pill count diaries, quality of life questionnaires, neuro exams, vital

signs

sheets, times of PK draws, etc.)

You will s

creen every new patient or patient returning to office with scan results and document appropriately on the patient tracking logs

You will c

omplete the study medication order form and have the physician or nurse practitioner sign orders prior to treatment and ensure that all medications, including

antiemetics

, are approved by the registrar prior to initiating treatment or when changing medication regimens, such as crossover studies

You will calculate

the BSA, creatinine clearance, urine

protein : creatinine

ratio or any other conversions needed per protocol

Obtain completed and signed waivers prior to

submitting

forms to enrollment coordinator for investigator-initiated protocols and re-consent patients

in a timely manner

and document process appropriately

You will accurately complete and

submit

follow

• up

serious adverse event (

SAE

report to the Safety Department within the

time frame

allotted by the Regulatory Department.

You should have :

An Associate of Nursing Degree; preferably Bachelor of Nursing Degree.

Knowledge of medical and oncology research terminology

and of

federal regulations, good clinical practices (GCP).

At least one year

of clinical nursing experience

At least one year of clinical research experience is preferred

At least one year of oncology nursing experience is preferred

Valid Registered Nurse license for the State of Texas

Interested candidates should submit their application through https : / / www.scri.com / careers / . Applications will be accepted through November 15, 2025. Please ensure all required materials are included as outlined in the posting.

About Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S.

Please

click here

to learn more about our research offerings.

We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.

As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.

We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.